Xiao-Jun Lin
Overview
Explore the profile of Xiao-Jun Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jiang W, Li X, Zhong W, Huang L, Lin X, Wen M, et al.
World J Emerg Med
. 2021 Sep;
12(4):287-292.
PMID: 34512825
Background: This study aims to compare the epidemiological, clinical and laboratory characteristics between patients with coronavirus disease (COVID-19) and influenza A (H1N1), and to develop a differentiating model and a...
12.
Li Q, Zhou Z, Lin X, Lao X, Cui B, Li S
BMC Gastroenterol
. 2019 Jun;
19(1):99.
PMID: 31221103
Background: Radical surgery for Bismuth type III/IV hilar cholangiocellular carcinoma, which was usually considered unresectable, seems to improve prognosis by increasing the surgical curability rate. However, the dilemma of multiple...
13.
He C, Zhang Y, Cai Z, Lin X
Endocr Connect
. 2019 Feb;
8(3):239-251.
PMID: 30726772
Aim The role of surgery in the treatment of metastatic pancreatic neuroendocrine tumors (PNETs) was controversial. The objectives of this study were to illustrate the impact of surgery in improving...
14.
Wei W, Jian P, Li S, Guo Z, Zhang Y, Ling Y, et al.
Cancer Commun (Lond)
. 2018 Oct;
38(1):61.
PMID: 30305149
Background: The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and...
15.
Xu C, Fu Q, Tao H, Lin X, Wang M, Xia S, et al.
Curr Med Sci
. 2018 Aug;
38(4):618-625.
PMID: 30128870
Postpartum hemorrhage (PPH) is one of the most adverse obstetric outcomes. Our aim is to detect the risks of multilevel PPH in different cesarean section (CS) groups [including nulliparous CS...
16.
He M, Zou R, Wei W, Shen J, Zhao M, Zhang Y, et al.
J Vasc Interv Radiol
. 2018 Jul;
29(8):1068-1077.e2.
PMID: 30042075
Purpose: To compare the stability of stable and unstable water-in-oil emulsions and the efficacy and safety of these emulsions in a single-center, prospective double-blind trial of transarterial chemoembolization for hepatocellular...
17.
Wang M, Fang H, Tao H, Cheng Z, Lin X, Cai M, et al.
J Huazhong Univ Sci Technolog Med Sci
. 2017 Oct;
37(5):681-692.
PMID: 29058280
China implemented the public hospital reform in 2012. This study utilized bootstrapping data envelopment analysis (DEA) to evaluate the technical efficiency (TE) and productivity of county public hospitals in Eastern,...
18.
He C, Lao X, Lin X
Chin J Cancer
. 2017 Jul;
36(1):59.
PMID: 28728568
Background: Patients with intermediate to advanced hepatocellular carcinoma (HCC) are most commonly treated with transarterial chemoembolization (TACE). Previous studies showed that TACE combined with recombinant human adenovirus type 5 (H101)...
19.
He C, Lin X
PLoS One
. 2017 Mar;
12(3):e0174769.
PMID: 28355305
Background: The systemic inflammatory response plays an important role in cancer development and progression. An original inflammation-based staging system for predicting survival in patients undergoing transarterial chemoembolization (TACE) combined with...
20.
Lin X, Lao X, Shi M, Li S
Dig Dis Sci
. 2016 Apr;
61(9):2465-76.
PMID: 27105647
Unlike systemic chemotherapy for hematological malignancies with hepatitis B virus (HBV) infection, transarterial chemoembolization (TACE) for HBV-related hepatocellular carcinoma (HCC) has only recently been reported to cause HBV reactivation and...